PharmaShots | Incisive News in 3 Shots

Subscribe Now

allergic diseases

Astellas Signs a Research and License Agreement with Xencor for Bispecific Antibody Program in Oncology

Astellas Signs a Research and License Agreement with Xencor for Bispecific Antibody Program in Oncology

April 3, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us